DK164202C - Farmaceutiske praeparatformer til topisk anvendelse indeholdende interferon-alfa og fremgangsmaade til deres fremstilling - Google Patents

Farmaceutiske praeparatformer til topisk anvendelse indeholdende interferon-alfa og fremgangsmaade til deres fremstilling

Info

Publication number: DK164202C
Authority: DK; Denmark
Prior art keywords: alfa; procedures; preparation; pharmaceutical preparations; topical use
Prior art date: 1986-02-05

Application number

DK058387A

Other languages

English (en)

Other versions

DK58387D0 (da

DK164202B (da

DK58387A (da

Inventor

Helmut Franz

Original Assignee

Thomae Gmbh Dr K

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-02-05

Filing date

1987-02-04

Publication date

1992-10-19

1987-02-04 Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K

1987-02-04 Publication of DK58387D0 publication Critical patent/DK58387D0/da

1987-08-06 Publication of DK58387A publication Critical patent/DK58387A/da

1992-05-25 Publication of DK164202B publication Critical patent/DK164202B/da

1992-10-19 Application granted granted Critical

1992-10-19 Publication of DK164202C publication Critical patent/DK164202C/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Inorganic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DK058387A 1986-02-05 1987-02-04 Farmaceutiske praeparatformer til topisk anvendelse indeholdende interferon-alfa og fremgangsmaade til deres fremstilling DK164202C (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE3603444		1986-02-05
DE19863603444 DE3603444A1 (de)	1986-02-05	1986-02-05	Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha

Publications (4)

Publication Number	Publication Date
DK58387D0 DK58387D0 (da)	1987-02-04
DK58387A DK58387A (da)	1987-08-06
DK164202B DK164202B (da)	1992-05-25
DK164202C true DK164202C (da)	1992-10-19

Family

ID=6293372

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK058387A DK164202C (da)	1986-02-05	1987-02-04	Farmaceutiske praeparatformer til topisk anvendelse indeholdende interferon-alfa og fremgangsmaade til deres fremstilling

Country Status (20)

Country	Link
EP (1)	EP0231816B1 (da)
JP (1)	JPS62209024A (da)
KR (1)	KR870007698A (da)
AT (1)	ATE63823T1 (da)
AU (1)	AU601712B2 (da)
CA (1)	CA1295242C (da)
DD (1)	DD284602A5 (da)
DE (2)	DE3603444A1 (da)
DK (1)	DK164202C (da)
ES (1)	ES2028796T3 (da)
FI (1)	FI86144C (da)
GR (1)	GR3002270T3 (da)
HU (1)	HU196560B (da)
IE (1)	IE59697B1 (da)
IL (1)	IL81472A0 (da)
NO (1)	NO169638C (da)
NZ (1)	NZ219169A (da)
PH (1)	PH24377A (da)
PT (1)	PT84243B (da)
ZA (1)	ZA87793B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5275804A (en) *	1986-02-25	1994-01-04	E. B. Michaels Research Associates, Inc.	Process and composition for oral hygiene
US5266310A (en) *	1987-09-17	1993-11-30	Boehringer Ingelheim International Gmbh	Stabilization of therapeutically active proteins in pharmaceutical preparations
DE3731255A1 (de) *	1987-09-17	1989-04-06	Boehringer Ingelheim Int	Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
DE3803312A1 (de) *	1988-02-04	1989-08-10	Gerd Prof Dr Med Gross	Verwendung eines interferonenthaltenden gels
NZ228285A (en) *	1988-03-11	1991-08-27	Teikoku Seiyaku Kk	Pharmaceutical composition comprising a polypeptide and adapted for intravaginal administration
EP0374257B1 (en) *	1988-05-06	1994-08-31	Toray Industries, Inc.	STABLE INTERFERON $g(b) COMPOSITION
US5244652A (en) *	1991-03-22	1993-09-14	E. B. Michaels Research Associates, Inc.	Viscous surface active composition
US5389676A (en) *	1991-03-22	1995-02-14	E. B. Michaels Research Associates, Inc.	Viscous surfactant emulsion compositions
US5863530A (en) *	1991-10-11	1999-01-26	Spruson & Ferguson	Treating ophthalmic fibrosis using interferon-α
JPH07501320A (ja) *	1991-10-11	1995-02-09	ギリーズ，マーク・セドリック	インタ−フェロン・アルファによる眼線維症の治療
US6630168B1 (en) *	1997-02-20	2003-10-07	Biomedicines, Inc.	Gel delivery vehicles for anticellular proliferative agents
FI106465B (fi) *	1998-06-10	2001-02-15	Suomen Punainen Risti Veripalv	Menetelmä virusturvallisten farmaseuttisten koostumusten valmistamiseksi
US6923966B2 (en)	1999-04-08	2005-08-02	Schering Corporation	Melanoma therapy
JP4536194B2 (ja) *	2000-02-17	2010-09-01	大日本住友製薬株式会社	安定な注射用製剤
RU2274442C2 (ru) *	2000-03-07	2006-04-20	Раш-Презбитериан-Ст. Лук'С Медикал Сентер	Композиции и способы улавливания и инактивации патогенных микроорганизмов и сперматозоидов
US6328987B1 (en) *	2000-11-03	2001-12-11	Jan Marini Skin Research, Inc.	Cosmetic skin care compositions containing alpha interferon
WO2003037375A1 (fr) *	2001-11-02	2003-05-08	Sekisui Chemical Co., Ltd.	Substance d'induction de cytokine et instrument d'induction de cytokine
US8137677B2 (en) *	2005-10-06	2012-03-20	Allergan, Inc.	Non-protein stabilized clostridial toxin pharmaceutical compositions
CA2761963C (en) *	2009-05-29	2018-03-20	Filligent Limited	Composition for use in decreasing the transmission of human pathogens
DK2819682T3 (da)	2012-03-01	2017-08-21	Firststring Res Inc	Topikale geler indeholdende alpha-connexin c-terminal (act) -peptider
JP6081156B2 (ja) *	2012-11-15	2017-02-15	アルケア株式会社	ハイドロゲル
DE102012222365A1 (de)	2012-12-05	2014-06-05	Aesculap Ag	Zusammensetzung zur Anwendung bei der Prophylaxe von post-chirurgischen Adhäsionen
CN105530950A (zh) *	2013-06-09	2016-04-27	艾弗兰纳特有限公司	包含Gc-巨噬细胞活化因子的组合物及其用途
CN110167516B (zh)	2017-01-31	2022-08-30	金伯利-克拉克环球有限公司	包含苯甲酸酯的抗细菌组合物及利用该组合物抑制细菌生长的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU1234383A (en) *	1982-03-17	1983-09-22	Inter-Yeda Ltd.	Interferon stabilised with polyvinyl-pyrrolidone
JPS6061535A (ja) *	1983-08-24	1985-04-09	エフ・ホフマン・ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト	製薬学的組成物
JPS6069037A (ja) *	1983-09-26	1985-04-19	Sunstar Inc	エリテマト−デス治療用外用剤
EP0139286B1 (en) *	1983-10-14	1991-08-21	Sumitomo Pharmaceuticals Company, Limited	Prolonged sustained-release preparations
US4680175A (en) *	1984-02-07	1987-07-14	Interferon Sciences, Inc.	Interferon administration vehicles
CA1248450A (en) *	1984-04-05	1989-01-10	Kazuo Kigasawa	Soft patch
JPS60228422A (ja) *	1984-04-26	1985-11-13	Suntory Ltd	安定化された生理活性物質製剤
JPS60260523A (ja) *	1984-06-07	1985-12-23	Asahi Chem Ind Co Ltd	インタ−フエロンの凍結乾燥医薬組成物

1986
- 1986-02-05 DE DE19863603444 patent/DE3603444A1/de not_active Withdrawn
1987
- 1987-01-21 EP EP87100792A patent/EP0231816B1/de not_active Expired - Lifetime
- 1987-01-21 AT AT87100792T patent/ATE63823T1/de not_active IP Right Cessation
- 1987-01-21 ES ES198787100792T patent/ES2028796T3/es not_active Expired - Lifetime
- 1987-01-21 DE DE8787100792T patent/DE3770280D1/de not_active Expired - Lifetime
- 1987-02-03 CA CA000528832A patent/CA1295242C/en not_active Expired - Lifetime
- 1987-02-03 DD DD87299676A patent/DD284602A5/de not_active IP Right Cessation
- 1987-02-03 FI FI870457A patent/FI86144C/fi not_active IP Right Cessation
- 1987-02-04 JP JP62024423A patent/JPS62209024A/ja active Pending
- 1987-02-04 IE IE29587A patent/IE59697B1/en not_active IP Right Cessation
- 1987-02-04 PT PT84243A patent/PT84243B/pt not_active IP Right Cessation
- 1987-02-04 HU HU87385A patent/HU196560B/hu not_active IP Right Cessation
- 1987-02-04 DK DK058387A patent/DK164202C/da not_active IP Right Cessation
- 1987-02-04 NO NO870441A patent/NO169638C/no unknown
- 1987-02-04 NZ NZ219169A patent/NZ219169A/en unknown
- 1987-02-04 AU AU68292/87A patent/AU601712B2/en not_active Ceased
- 1987-02-04 IL IL81472A patent/IL81472A0/xx not_active IP Right Cessation
- 1987-02-04 ZA ZA87793A patent/ZA87793B/xx unknown
- 1987-02-05 KR KR870000912A patent/KR870007698A/ko not_active Application Discontinuation
- 1987-02-05 PH PH34815A patent/PH24377A/en unknown
1991
- 1991-07-08 GR GR91400966T patent/GR3002270T3/el unknown

Also Published As

Publication number	Publication date
HUT43494A (en)	1987-11-30
NZ219169A (en)	1990-04-26
PH24377A (en)	1990-06-13
KR870007698A (ko)	1987-09-21
JPS62209024A (ja)	1987-09-14
AU6829287A (en)	1987-08-06
FI86144C (fi)	1992-07-27
GR3002270T3 (en)	1992-12-30
PT84243A (de)	1987-03-01
FI870457A0 (fi)	1987-02-03
DE3770280D1 (de)	1991-07-04
EP0231816B1 (de)	1991-05-29
DK58387D0 (da)	1987-02-04
HU196560B (en)	1988-12-28
FI870457A (fi)	1987-08-06
IE59697B1 (en)	1994-03-23
DK164202B (da)	1992-05-25
ATE63823T1 (de)	1991-06-15
DE3603444A1 (de)	1987-08-06
NO870441D0 (no)	1987-02-04
NO169638C (no)	1992-07-22
DD284602A5 (de)	1990-11-21
ES2028796T3 (es)	1992-07-16
IE870295L (en)	1987-08-05
NO169638B (no)	1992-04-13
CA1295242C (en)	1992-02-04
EP0231816A3 (en)	1987-09-23
DK58387A (da)	1987-08-06
PT84243B (pt)	1989-09-14
ZA87793B (en)	1988-10-26
EP0231816A2 (de)	1987-08-12
FI86144B (fi)	1992-04-15
NO870441L (no)	1987-08-06
AU601712B2 (en)	1990-09-20
IL81472A0 (en)	1987-09-16

Publication	Publication Date	Title
DK164202C (da)	1992-10-19	Farmaceutiske praeparatformer til topisk anvendelse indeholdende interferon-alfa og fremgangsmaade til deres fremstilling
DK203787D0 (da)	1987-04-22	Praeparat til nasal administrering
ES2009216A6 (es)	1989-09-16	Metodo de preparar un derivado de interleucina-lalfa.
DK362189A (da)	1990-01-22	Farmaceutisk praeparat til intravenoes indgift
ATE144704T1 (de)	1996-11-15	Mittel zur topischen verabreichung von arzneiwirkstoffen
IT8647666A0 (it)	1986-02-18	Peptidi e derivati peptidici, loro preparazione e loro impiego come medicamenti
ATE65912T1 (de)	1991-08-15	Arzneimittelzusammensetzungen ermaessigter toxizitaet.
DK409786D0 (da)	1986-08-28	6-phenoxymethyl-4-hydroxytetrahydropyran-2-oner, fremgangsmaade til fremstilling deraf, deres anvendelse som laegemidler, pharmaceutiske praeparater og mellemprodukter
DK144885D0 (da)	1985-03-29	Substituerede 4-hydroxybenzopyraner eller farmaceutisk acceptable additionssalte deraf, deres fremstilling og anvendelse som laegemidler
DK179786D0 (da)	1986-04-18	(-)-1beta-ethyl-1alfa-hydroxylmethyl-1,2,3,4,6,7,12,12balfa-octa-hydroindolo(2,3-a)quinolizin og syreadditionssalte deraf, deres fremstilling og anvendelse som farmaceutika
MY104088A (en)	1993-11-30	Peptide-drugs compositions containing (alpha)-aminoboroic acid derivatives.
IT1223132B (it)	1990-09-12	Composizione farmaceutica per somministrazione nasale
ES2054029T3 (es)	1994-08-01	Formulacion de acetato de flecainida con liberacion controlada.
EP0355899A3 (en)	1991-03-20	Nucleotide derivatives
DK454588D0 (da)	1988-08-12	Substituerede thienoimidazolderivater, deres fremstilling, farmaceutiske praeparater deraf og deres anvendelse som mavesyresekretionshaemmende midler
ES2091571T3 (es)	1996-11-01	Nuevos derivados peptidicos activos en los procesos de adhesion celular, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
IT8819541A0 (it)	1988-02-25	Composizione farmaceutica per somministrazione nasale.
IT8520150A0 (it)	1985-03-29	Nuovi derivati ad attivita'terapeutica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
LV5757A4 (lv)	1996-12-20	Jauni ligstosas izdalisanas farmaceitiski preparati
DK454185A (da)	1986-04-06	Aminosyrederivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner
ATE68975T1 (de)	1991-11-15	Zur stimulierung der traenensekretion verwendbare pharmazeutische praeparate.
ES2135424T3 (es)	1999-11-01	Composicion oral a base de ibuprofeno.
IL81926A0 (en)	1987-11-30	Pharmaceutical compositions for the oral administration of active proteins

Legal Events

Date	Code	Title	Description
1996-10-14	PBP	Patent lapsed